Bone Grafts And Substitutes Market Size (2024 - 2029)

Bone Grafts And Substitutes Market Analysis

The Bone Grafts And Substitutes Market size is estimated at USD 3.95 billion in 2024, and is expected to reach USD 5.70 billion by 2029, growing at a CAGR of 5.70% during the forecast period (2024-2029).

The major factors driving the growth of the bone grafts and substitutes market include the rising number of road injuries and joint disorders, the development of biocompatible synthetic bone grafts, and the increase in demand for dental bone grafts.

The rising incidence of road injuries and the prevalence of joint disorders are the key factors driving the demand for bone grafting. According to the French Road Safety Observatory report published in February 2024, 1,101 individuals were reported with serious injuries in January 2024 in France, mirroring the figures from January 2023. Thus, the growing burden of road accidents and the subsequent increase in bone-related injuries is expected to drive the market growth.

Furthermore, the rising company activities in launching advanced products are expected to increase the demand for bone grafts and substitutes, thereby boosting market growth. For instance, in August 2023, Stimlabs LLC unveiled Relese, an allograft made from a fenestrated dehydrated complete human placental membrane (dCHPM), targeting both chronic and acute wounds. Relese acts as a selective barrier, featuring channels that facilitate wound fluid drainage while safeguarding the wound from external elements. This thicker, specialized allograft boasts superior handling properties, rendering it suitable for a wide array of clinical applications.

Additionally, the increase in regulatory approvals for various bone graft products is expected to boost the market growth over the forecast period. For instance, in October 2023, Orthofix Medical Inc., a leading global spine and orthopedics company, received the 510k clearance and a full commercial launch of OsteoCove, an advanced bioactive synthetic graft. Available in both a putty and strip configuration, OsteoCove was carefully formulated to provide superior bone-forming capabilities with best-in-class handling characteristics for a wide range of spine and orthopedic procedural applications. Thus, owing to the strategic product launches of bone grafts and significant regulatory clearances, the market studied is expected to grow significantly over the forecast period.

Thus, owing to the increase in the incidence of bone-related diseases and product launches by key players, the market studied is expected to witness significant growth over the coming years. However, factors such as the high cost of surgeries and ethical issues related to bone grafting are likely to restrain the market growth over the forecast period.

Bone Grafts And Substitutes Industry Segmentation

As per the scope of the report, bone graft is a surgical procedure in which diseased or damaged bones are repaired and rebuilt using transplanted bones. These are implantable materials that promote bone healing, bone formation, and osseous reconstruction due to their osteoconductive, osteogenic, and osteoinductive properties. Bone grafts can also be used to fill voids in case of the absence of bones or to provide structural stability.

The bone grafts and substitutes market is segmented by product, application, and geography. By product, the market is segmented into allografts, bone graft substitutes, and other products. By application, the market is segmented into craniomaxillofacial, dental, joint reconstruction, spinal fusion, and other applications. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. For each segment, the market size and forecast are provided in terms of value (USD).